CORRESP Filing
bioAffinity Technologies, Inc.
Date: Sept. 16, 2025 · CIK: 0001712762 · Accession: 0001493152-25-013610
AI Filing Summary & Sentiment
File numbers found in text: 333-289944
Show Raw Text
CORRESP 1 filename1.htm bioAffinity Technologies, Inc. 3300 Nacogdoches Road, Suite 216 San Antonio, Texas 78217 (210) 698-5334 September 16, 2025 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Robert Augustin Re: bioAffinity Technologies, Inc. Registration Statement on Form S-1 Filed August 29, 2025 File No. 333-289944 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), bioAffinity Technologies, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 16, 2025, or as soon thereafter as possible. Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. Very truly yours, BIOAFFINITY TECHNOLOGIES, INC. By: /s/ Maria Zannes Name: Maria Zannes Title: Chief Executive Officer